Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
The International Agranulocytosis and Aplastica Anemia Study.
Risk of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics.
JAMA, 256 (1986), pp. 1749-1757
[2.]
H. Jick, L.E. Derby, L.A. García Rodríguez, S.S. Jick, A.D. Dean.
Nonsteroidal antiinflamatory drugs and certain rare, seroius adverse events: a cohort study.
Pharmacotherapy, 13 (1993), pp. 212-217
[3.]
M. Sanal, M. Gur-Lavi.
Reversible bone marrow aplasia induced by naproxen.
Ann Hematol, 65 (1992), pp. 59-60
[4.]
N. Nygard, G. Starkebaum.
Naproxen and agranulocytosis.
JAMA, 258 (1987), pp. 3259
[5.]
L.A. García-Rodríguez, R. Williams, L.E. Derby.
Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors.
Arch Intern Med, 154 (1994), pp. 311-316
[6.]
Y. Furet, E.H. Metman, M. Breteau, J. Bertrand.
Hepatitis due to nonsteroidal anti-inflamatory agents.
Ann Gastroenterol Hepatol, 23 (1987), pp. 367-374
Copyright © 2005. Elsevier España S.L. Barcelona
